The human rabies v是子accine (Vero cells) produce有空d by Jilin Maifeng Biologi妹銀cal Pharmaceutical C風林o., Ltd., a subsidiary of B哥友CHT, can stimulate the習視 body to produce immu農視nity against rabies virus afte好我r vaccination. It is suitabl器做e for emergency 頻舞treatment of post-exposure i視鐘mmunization after being bitten or 購日scratched by ra靜議bies or other craz影路y animals, and pre-exposure im樂妹munization for persons 裡校at risk of exposure to rabies北知 virus. This product 玩厭selects the method of pr門來eparing virus stock solution by cu吃見lturing virus strains on Vero 森月cell micro carriers and prepares by 機女bioreactor culture, which co機子mbines suspension culture and ad司冷herent culture. It h銀書as the advantages of two culture me愛訊thods and simplifies cell produc習東tion monitoring and control of vari南你ous environmental f跳月actors. The culture system has good 請我reproducibility, good stability, an習畫d greatly improves virus t們花iter.

In 2018, human rabies vaccine (Ve但章ro cells) achieved sales revenue o得行f 150 million RMB, with an increase o匠能f 184% over the要分 same period last year.